Gerald Flattmann Jr.

King & Spalding

+ Follow Contact

Latest Posts › Labeling

Share:

GSK v. Teva and Induced Infringement by AB-Rated Generics: Where Are We Now?

The Federal Circuit’s October 2020 split decision in GSK v. Teva made waves throughout the pharmaceutical industry and among Hatch-Waxman litigators. In the broadest reading, some see the majority opinion as rendering any...more

2/15/2021 / Food and Drug Administration (FDA) , Generic Drugs , Labeling , Manufacturers , Patent Infringement , Patent Litigation , Pharmaceutical Industry , Pharmaceutical Patents , Prescription Drugs

1 Results

View per page

Page: of 1

Gerald Flattmann Jr.

King & Spalding

Popular Topics by This Author

Latest Posts › Labeling

GSK v. Teva and Induced Infringement by AB-Rated Generics: Where Are We Now?

"My best business intelligence, in one easy email…"